Randomized, double-blind, placebo-controlled imaging study in schizophrenia
Performance of working and episodic memory tasks associated with brain activation
AQW051 (7.5 mg) associated with significant effects on episodic memory vs placebo
AQW051 did not significantly improve working memory in study participants.
AQW051 was well tolerated with an acceptable safety profile.